LifePath OI Ecosystem
DSK V1.0
Commercial Overview · Organic Intelligence Group LLC © 2026
The Problem We Solve
Regulated industries (healthcare, finance, public sector) cannot deploy AI decisions that change their answer for identical input. Today's LLM-driven systems are probabilistic: same prompt, different outcome. That non-determinism fails every audit, breaks compliance, and makes every automated decision legally indefensible.
DSK V1.0 is a deterministic decision kernel: identical input always yields identical, hash-verifiable output. It is the missing infrastructure layer for decisions that must be reproducible, auditable, and provable in a court of law.
Regulated decision systems where every automated outcome must be reproducible on audit.
Target Market
Healthcare
Clinical triage, prior-auth, drug-interaction decisions under HIPAA & FDA Part 11.
Finance
Credit adjudication, AML alerts, trade-surveillance determinism for SOX & SR 11-7.
Public Sector
Benefits eligibility, visa adjudication, automated compliance under OMB / EU AI Act.
Addressable: regulated decision systems where every automated outcome must be reproducible on audit.
Three commercial paths — per-decision usage, enterprise license, and supervised bridge access.
Pricing Model
Per-Decision
Usage-priced kernel resolutions for pilots & evaluation tiers.
Enterprise License
Annual platform license with governed bridge access for in-house teams.
Bridge-Access Tier
Time-boxed, supervised engineer connections for integration & verification.
3-Year Adoption Ramp (Estimate)
Year 1
2–3 design-partner pilots in healthcare & finance; bridge-access revenue; reference deployments.
Year 2
Enterprise licenses in regulated verticals; first public-sector eligibility deployment.
Year 3
Platform scale across regulated decision systems; per-decision volume economics.
Estimates only — directional, not guidance.
Live mandates now require traceability, reproducibility, and auditability for high-risk automated decisions.
Why Now
EU AI Act
High-risk AI systems require traceability, reproducibility, and auditability — live 2026.
FDA 21 CFR Part 11
Electronic decision records must be reproducible and tamper-evident for regulated devices.
HIPAA Determinism
Clinical decision support acting on identical input must produce identical, auditable output.
These are live regulatory tailwinds — regulated buyers now have a compliance mandate to procure determinism.
Pilot Pipeline (Placeholder)
Clinical Triage (Healthcare)
In discussions — target design partnerCredit Adjudication (Finance)
Target vertical — outreach Q4Benefits Eligibility (Public Sector)
Target vertical — monitored RFP pipelinePlaceholder — concrete pilot verticals and status to be updated as engagements solidify.
IP-Safe Commercial Overview — Organic Intelligence Group LLC © 2026
Market · Where DSK Applies
Regulated decision systems — healthcare, finance, public sector — where every automated outcome must be reproducible on audit.